Market research
S6UQ.F Liberty Health Sciences Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 327M
- P/E ratio
- 14.13
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.52
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- Not available
- Market cap
- 327M
- P/E ratio
- 14.13
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.52
About
About Liberty Health Sciences Inc
Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis in the United States. The company offers medical cannabis in the State of Florida through the Florida Department of Health, office of medical marijuana use. As of February 24, 2021, it operated 31 dispensaries in Florida. The company is headquartered in Gainesville, Florida. As of February 26, 2021, Liberty Health Sciences Inc. operates as a subsidiary of Ayr Wellness Inc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the S6UQ.F discussion.
5 years, 5 months ago
Liberty Health Sciences Inc is currently in a long term uptrend where the price is trading 89.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.4.
Liberty Health Sciences Inc's total revenue sank by 19.1% to $13M since the same quarter in the previous year.
Its net income has dropped by 130.6% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 136.6% to $-2M since the same quarter in the previous year.
Based on the above factors, Liberty Health Sciences Inc gets an overall score of 2/5.